Wockhardt partners with RDIF to produce and supply Sputnik vaccines
Capital MarketThe Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund), and Wockhardt, a global pharmaceutical company headquartered in India, have partnered to produce and supply Sputnik V and Sputnik Light vaccines against COVID-19.
The agreement was reached under the aegis of Enso Healthcare (part of Enso Group), RDIF's coordination partner for sourcing Sputnik V vaccines in India.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
